Skip to content
FolioFact
FolioFact
Q2 2026 7/58 funds filed
Newest stored record
Sign in Sign up

Voss Capital — CGTX

How Voss Capital's position in Cognition Therapeutics Inc. changed quarter by quarter. Change badges compare each quarter to the fund's immediately-prior filing.

Quarters held
2
First reported
Q4 2025
Latest value
$151,900
Latest weight
0%
Peak weight
0%
Shares since first
-28.4%

Position Trend

Shares, value, and weight from first report to latest report.

Voss Capital first reported 279,340 shares in Q4 2025 and most recently reported 200,000 shares in Q1 2026. Portfolio weight peaked at 0% in Q4 2025; the low reported weight was 0% in Q1 2026.

Since the first report, shares are -28.4% and reported value is -59.7%. Latest move: TRIM

Quarter Shares Value % of portfolio Change
Q1 2026 200,000 $151,900 0.01% TRIM
Q4 2025 279,340 $377,109 0.02% NEW